Are you Dr. Swanson?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 44 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2401 S 31st St
Temple, TX 76508Phone+1 254-724-2111
Summary
- Dr. Gregory Swanson, MD is a radiation oncologist in Temple, Texas. He is currently licensed to practice medicine in Texas, Washington, and Minnesota. He is affiliated with Baylor Scott & White Medical Center - Temple and is a Professor at TX A&M Univ Coll of Med.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Radiation Oncology, 1986 - 1989
- University of Texas at Austin Dell Medical SchoolInternship, Transitional Year, 1985 - 1986
- McGovern Medical School at UTHealthClass of 1985
Certifications & Licensure
- TX State Medical License 1986 - 2026
- WA State Medical License 1999 - 2006
- MN State Medical License 1986 - 1989
- American Board of Radiology Radiation Oncology
Clinical Trials
- Docetaxel, Radiation Therapy, and Prednisone in Treating Patients Who Have Undergone Surgery For Prostate Cancer Start of enrollment: 2006 May 01
- Study to Assess the Activity of Nexrutine® in Prostate Cancer Patients Start of enrollment: 2011 Jul 01
Publications & Presentations
PubMed
- 1 citationsNTCP Modeling and Dose-Volume Correlations of Significant Hematocrit Drop 3 Months After Prostate Radiation Therapy.Panos Papanikolaou, Gregory Swanson, Sotirios Stathakis, Panayiotis Mavroidis
Advances in Radiation Oncology. 2024-03-01 - Salvage prostate bed plus elective pelvic node radiation without androgen deprivation therapy.Gregory P Swanson, Kendall Hammonds, Sameer Jhavar
Journal of Cancer Research and Clinical Oncology. 2023-11-01 - 2 citationsThe cost of elective nodal coverage in prostate cancer: Late quality of life outcomes and dosimetric analysis with 0, 45 or 54 Gy to the pelvis.Garrett L Jensen, Sameer G Jhavar, Chul S Ha, Kendall P Hammonds, Gregory P Swanson
Clinical and Translational Radiation Oncology. 2022-09-01